Technology
Health
Biotechnology

PDS Biotechnology

$5.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.18%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PDSB and other stocks, options, ETFs, and crypto commission-free!

About

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. Read More The company was founded on March 15, 2019 and is headquartered in Berkeley Heights, NJ.

Employees
10
Headquarters
Berkeley Heights, New Jersey
Founded
2019
Market Cap
29.18M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
55.16K
High Today
$5.91
Low Today
$5.62
Open Price
$5.91
Volume
38.91K
52 Week High
$25.40
52 Week Low
$5.03

Collections

Technology
Health
Biotechnology
2018 IPO

Earnings

-$1.27
-$1.13
-$0.99
-$0.85
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.